| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Basic helix loop helix PAS protein MOP2 ELISA Kit; Basic-helix-loop-helix-PAS protein MOP2 ELISA Kit; bHLHe73 ELISA Kit; Class E basic helix-loop-helix protein 73 ELISA Kit; ECYT4 ELISA Kit; Endothelial PAS domain containing protein 1 ELISA Kit; Endothelial pas domain protein 1 ELISA Kit; Endothelial PAS domain-containing protein 1 ELISA Kit; EPAS 1 ELISA Kit; EPAS-1 ELISA Kit; EPAS1 ELISA Kit; EPAS1_HUMAN ELISA Kit; HIF 1 alpha like factor ELISA Kit; HIF 2 alpha ELISA Kit; HIF-1-alpha-like factor ELISA Kit; HIF-2-alpha ELISA Kit; HIF2-alpha ELISA Kit; HIF2A ELISA Kit; HLF ELISA Kit; Hypoxia inducible factor 2 alpha ELISA Kit; Hypoxia inducible factor 2 alpha subunit ELISA Kit; Hypoxia-inducible factor 2-alpha ELISA Kit; Member of PAS protein 2 ELISA Kit; Member of pas superfamily 2 ELISA Kit; MOP 2 ELISA Kit; MOP2 ELISA Kit; PAS domain-containing protein 2 ELISA Kit; PASD2 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
hypoxia-inducible factor 2(HIF-2) (EPAS1) is a biological molecule commonly studied in cardiovascular research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: Q99814
Biological context
Researchers often monitor hypoxia-inducible factor 2(HIF-2) in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as vascular biology and endothelial function, cardiac remodeling and injury responses, and thrombosis and hemostasis. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in hypoxia-inducible factor 2(HIF-2) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, endothelial markers, coagulation-related proteins, and cardiac injury markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, hypoxia-inducible factor 2(HIF-2) may also appear under names such as Basic helix loop helix PAS protein MOP2 and Basic-helix-loop-helix-PAS protein MOP2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that hypoxia-inducible factor 2(HIF-2) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites through Endothelial Fatty Acid Uptake
D Pirri,/,2023
Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases
LV Spirina,Cells ,2020
Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis
Spirina LV.et al,Mol Biol (Mosk),2017